OMAHA, Neb., April 19, 2016 -- Green Plains Partners LP (NASDAQ:GPP) today announced that Green Plains Inc. appointed Brett C. Riley as an independent member of the board of our general partner, Green Plains Holdings LLC. Riley will also serve as chairman of the board’s conflicts committee and member of the board’s audit committee. He is the partnership’s second independent member of the board.
“Brett brings a wealth of business development experience to our board,” commented Todd Becker, president and chief executive officer of Green Plains Partners. “His depth and breadth of industry knowledge will prove to be valuable as we grow the partnership.”
Riley led the strategy and mergers and acquisitions activities for Magellan Midstream Partners, L.P., a publicly traded master limited partnership, from June 2003 until April 2016. From 2007 to April 2016, Riley served as senior vice president, business development for Magellan GP, LLC, the general partner of Magellan Midstream Partners. Prior to joining Magellan GP, Riley served as director, mergers and acquisitions and director, financial planning and analysis for a subsidiary of The Williams Companies, Inc. Before that, he held various finance and business development positions with MAPCO Inc. and The Williams Companies, Inc. Riley received his Bachelor of Business Administration in management from Pittsburg State University and his Master of Business Administration from the University of Tulsa.
About Green Plains Partners LP
Green Plains Partners LP (NASDAQ:GPP) is a fee-based Delaware limited partnership formed by Green Plains Inc. to provide fuel storage and transportation services by owning, operating, developing and acquiring ethanol and fuel storage tanks, terminals, transportation assets and other related assets and businesses.
Contact Jim Stark Vice President, Investor & Media Relations 402.884.8700 [email protected]


Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 



